LEVO-DROMORAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levo-dromoran, and when can generic versions of Levo-dromoran launch?
Levo-dromoran is a drug marketed by Valeant Pharm Intl and is included in two NDAs.
The generic ingredient in LEVO-DROMORAN is levorphanol tartrate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levo-dromoran
A generic version of LEVO-DROMORAN was approved as levorphanol tartrate by HIKMA on March 31st, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVO-DROMORAN?
- What are the global sales for LEVO-DROMORAN?
- What is Average Wholesale Price for LEVO-DROMORAN?
Summary for LEVO-DROMORAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| DailyMed Link: | LEVO-DROMORAN at DailyMed |
US Patents and Regulatory Information for LEVO-DROMORAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | LEVO-DROMORAN | levorphanol tartrate | INJECTABLE;INJECTION | 008719-001 | Dec 19, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Pharm Intl | LEVO-DROMORAN | levorphanol tartrate | TABLET;ORAL | 008720-001 | Dec 19, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
